Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 34, no. 9, pp. –, 2002
Abstract
Keywords
- National Center for Biotechnology Information
- NCBI
- NLM
- MEDLINE
- humans
- pubmed abstract
- nih
- national institutes of health
- national library of medicine
- adult
- female
- middle aged
- drug resistance
- anti-infective agents
- trimethoprim
- bacterial / genetics
- r raz
- sulfamethoxazole drug combination / therapeutic use*
- urinary tract infections / drug therapy*
- women
- urinary / therapeutic use*
- investigators=[]
- affs=[])
- pmid:11941541
- doi:10.1086/339812
- b chazan
- collabauthor(name='israeli urinary tract infection group'
- cystitis / drug therapy
- gene frequency
- premenopause
How to cite
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W. (2002). Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34(9), –. http://www.ncbi.nlm.nih.gov/pubmed/11941541
r2002clinicalempiric
Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.
References
No references are recorded for this paper yet.
